Autopsy report · NCT02200354

The Safety and Efficacy of Pemetrexed Rechallenge With Bevacizumab

“inclusion speed”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 4 years 8 months before it stopped.
• 20 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Kobe City General Hospital

Sponsor type

University, hospital or other

Conditions

Advanced Non-small Cell Lung Cancer

Interventions

pemetrexed with bevacizumab

Participants

20

Sites

1

Countries

Japan

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.